February 2024 Supplement - Endovascular Today

Table of Contents

Supplement

February 2024 Supplement

Transforming CLTI

New data and current best practices for limb salvage using Inari LimFlow’s TADV

In This Supplement

Download PDF

Digital Supplement

Q&A: PROMISE II Experience and Data Overview

Coprincipal Investigators from PROMISE II discuss the uniqueness of the recently published study, patient population characteristics, key highlights from the data, and more.

With Daniel Clair, MD, and Mehdi H. Shishehbor, DO, MPH, PhD

TADV Treatment Effect

Results of a propensity stratification against the CLariTI study, a prospective cohort study of the natural history of patients with no-option CLTI.

By Anahita Dua, MD, and Richard Powell, MD

Health Economics: Inari LimFlow Procedure

Highlights from a recent study demonstrating the cost-effectiveness of TADV for no-option CLTI patients.

By Peter A. Schneider, MD

An Overview of the Inari LimFlow Procedure

A case example and step-by-step guide to TADV with Inari LimFlow.

By Miguel Montero-Baker, MD

Latest Postprocedure Wound Care: Best Practices

The first 2 months after TADV are a critical time for monitoring wound progression and infection control.

By Brian Lepow, DPM

TADV Circuit Maturation and Pressure Wire Experience

How pressure gradient measurements can monitor remodeling during TADV.

By Roberto Ferraresi, MD

How Will TADV Change Clinical Practice?

TADV can offer no-option patients hope for limb preservation and will become part of the armamentarium for vascular specialists.

By Daniel Clair, MD

Indications for Use

Latest Issues

March 2026

February 2026

January 2026

December 2025

November 2025

View All Issues

In This Supplement

Most Read Articles